Detalhe da pesquisa
1.
Optical coherence tomography outcomes from SPRINT-MS, a multicenter, randomized, double-blind trial of ibudilast in progressive multiple sclerosis.
Mult Scler
; 27(9): 1384-1390, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33054533